Bristol-Myers Squibb: Thrombosis trials

The registry lists 28 Thrombosis studies with Bristol-Myers Squibb as lead sponsor. 0 are open to participants now and 11 have results posted.

Phase 1 15Phase 2 6Phase 3 6No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate BMS-986141 Added on to Aspirin or Ticagrelor or the Combination, on Thrombus Formation in a Thrombosis Chamber Model in Participants With Stable Coronary Artery Disease and Healthy ParticipantsCompletedNCT05093790Phase 2Results posted
• A Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring AnticoagulationCompletedNCT02981472Phase 2Results posted
• Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes"CompletedNCT02671461Phase 2Results posted
• Bioavailability of Apixaban Crushed TabletCompletedNCT02101112Phase 1Results posted
• Pediatric Catheter-related Thrombosis Imaging StudyCompletedNCT01137578Not applicableResults posted
• Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary EmbolismCompletedNCT00643201Phase 3Results posted
• Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary EmbolismCompletedNCT00633893Phase 3Results posted
• Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical IllnessCompletedNCT00457002Phase 3Results posted
• Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement SurgeryCompletedNCT00452530Phase 3Results posted
• Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3)CompletedNCT00423319Phase 3Results posted
• A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) CancerCompletedNCT00320255Phase 2Results posted
• Pharmacokinetic and Metabolism of [14^C] BMS-986177 in Healthy Male ParticipantsCompletedNCT03939702Phase 1
• Evaluate the Pharmacokinetics of BMS-986177 From Two Formulations in Healthy ParticipantsCompletedNCT03362437Phase 1
• To Evaluate the Safety and Pharmacokinetics of BMS-986177 in Healthy Japanese ParticipantsCompletedNCT03224260Phase 1
• A Short and Long Intravenous Infusion Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-962212 in Healthy SubjectsCompletedNCT03197779Phase 1
• Evaluate Pharmacokinetics and Safety of BMS-986177 in Participants With Normal Renal Function and With Moderate or Severe Renal ImpairmentCompletedNCT03196206Phase 1
• Single-dose Pharmacokinetics of BMS-986177 in Participants With Hepatic Impairment Compared to Healthy ParticipantsCompletedNCT02982707Phase 1
• A Study to Evaluate the Effect of Rifampin on the Single-dose Pharmacokinetics of BMS-986177 in Healthy SubjectsCompletedNCT02959060Phase 1
• A Study to Evaluate the Safety and Pharmacokinetics of BMS-986177 in Participants With End-stage Renal Dysfunction on Chronic Stable Hemodialysis TreatmentCompletedNCT02902679Phase 1
• A Study to Evaluate the Effect of Co-administration of Itraconazole or Diltiazem on the Pharmacokinetics of BMS-986177 in Healthy SubjectsCompletedNCT02807909Phase 1
• Safety and Tolerability Study of BMS-986177 in Healthy SubjectsCompletedNCT02608970Phase 1
• CV004-007 Thrombosis Chamber StudyCompletedNCT02439190Phase 1
• Early Post-Marketing Study of ELIQUIS (Apixaban) in MexicoCompletedNCT02345343
• Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986141 in Healthy SubjectsCompletedNCT02341638Phase 1
• Study to Evaluate a Single Dose of Apixaban in Pediatric Participants at Risk for a Thrombotic DisorderCompletedNCT01707394Phase 1
• Ex Vivo Human Thrombosis Chamber StudyCompletedNCT00935506Phase 1
• Oral Direct Factor Xa-inhibitor Apixaban in Patients With Acute Symptomatic Deep-vein Thrombosis-The Botticelli DVT StudyCompletedNCT00252005Phase 2
• BMS-562247 in Subjects Undergoing Elective Total Knee Replacement SurgeryCompletedNCT00097357Phase 2/3